BEGIN:VCALENDAR
METHOD:PUBLISH
PRODID:Microsoft Exchange Server 2010
VERSION:2.0
BEGIN:VTIMEZONE
TZID:tzone://Microsoft/Utc
BEGIN:STANDARD
DTSTART:16010101T000000
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:16010101T000000
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
ORGANIZER;CN=Kate Boehner:mailto:kate.b@jhu.edu
DESCRIPTION:Please join us for the weekly Tuberculosis Research Advancement
  Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2\, 1M.13 o
 r via Zoom\n\nThursday\, February 22nd\n“Lesion-centric PK/PD considerat
 ions for TB drug discovery and regimen design”\n\n[Jan]<https://tbcenter
 .jhu.edu/event/trac-seminar-series-34/headshot_jansysarathy_2022/>\n\nJans
 y Sarathy\, PhD\nAsst. Member\, Center for Discovery and Innovation HMH\nA
 sst. Professor\, Hackensack Meridian School of Medicine\n\nDr. Sarathy gra
 duated from National University of Singapore\, School of Medicine after th
 e completion of a graduate research program at the Novartis Institute for 
 Tropical Diseases. She was a postdoctoral research fellow at the Public He
 alth Research Institute\, Rutgers\, where she trained under veteran TB pha
 rmacologist Dr. Veronique Dartois. She then pursued a faculty position at 
 the Center for Discovery and Innovation. Dr. Sarathy’s research focuses 
 on applying site-of-disease pharmacokinetic-pharmacodynamic (PK-PD) concep
 ts to provide pharmacological rationale for TB treatment efficacy.\n\nThe 
 February TRAC Seminar Series is presented by the Pharmocology and Pharmaco
 metrics Cor<https://tbcenter.jhu.edu/trac/core-programs/pharmacology/>e.\n
 \nJoin via Zoom – **New link w/ Passcode**\nhttps://jhjhm.zoom.us/j/9951
 2605810?pwd=NitKVjhqOFRCVURneE12Z2FzN21DQT09\nMeeting ID: 995 1260 5810\nP
 asscode: 107907\n\n\n
UID:040000008200E00074C5B7101A82E00800000000E07F77410061DA01000000000000000
 0100000000745542C34305748B7BAC5E4635E7B81
SUMMARY:2/22 TRAC Seminar: Lesion-centric PK/PD considerations for TB drug 
 discovery and regimen design
DTSTART:20240222T170000Z
DTEND:20240222T180000Z
CLASS:PUBLIC
PRIORITY:5
DTSTAMP:20240216T174750Z
TRANSP:OPAQUE
STATUS:CONFIRMED
LOCATION;ALTREP=:Hybrid: Zoom & CRB-2\, 1M.13
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
X-MICROSOFT-CDO-INTENDEDSTATUS:BUSY
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
X-MICROSOFT-CDO-IMPORTANCE:1
X-MICROSOFT-CDO-INSTTYPE:0
X-MICROSOFT-ONLINEMEETINGEXTERNALLINK:
X-MICROSOFT-ONLINEMEETINGCONFLINK:
X-MICROSOFT-DONOTFORWARDMEETING:FALSE
X-MICROSOFT-DISALLOW-COUNTER:FALSE
X-MICROSOFT-LOCATIONDISPLAYNAME:Hybrid: Zoom & CRB-2\, 1M.13
X-MICROSOFT-LOCATIONSOURCE:LocationServices
X-MICROSOFT-LATITUDE:0
X-MICROSOFT-LONGITUDE:0
BEGIN:VALARM
DESCRIPTION:REMINDER
TRIGGER;RELATED=START:-PT15M
ACTION:DISPLAY
END:VALARM
END:VEVENT
END:VCALENDAR
